Young adult smokers frequently encounter the health care system as parents coming in for their child’s medical visit. Child health care clinicians, however, do not typically provide smoking cessation assistance to parents.

This national cluster-randomized trial demonstrates that a tobacco dependence intervention for parents can be effectively implemented in routine pediatric outpatient practice. (Read the full article)

Despite declines in cigarette smoking, smokeless tobacco use among youth has remained unchanged in the United States. Modified or novel smokeless tobacco products are being increasingly promoted to youth in the United States as an alternative to smoking.

Among US students in grades 6 through 12, 5.0% used snuff or chewing or dipping tobacco, whereas 2.2% used snus or dissolvable tobacco products. Approximately two-thirds of smokeless tobacco users concurrently smoked combustible tobacco; risk perception of all tobacco products was protective of smokeless tobacco use. (Read the full article)

Prosmoking messages, delivered through marketing and the media, can reach very young children and influence attitudes and behaviors around smoking.

Marketing of tobacco and cigarette brands has successfully reached young children in low- and middle-income countries. More effective measures are needed to restrict the reach of tobacco marketing. (Read the full article)

Youth are frequent consumers of movies that contain high levels of violence, and violent content in films, especially those rated PG-13, has been increasing over time.

Content analyses seldom examine how violence is portrayed with other health risk behaviors, such smoking, drinking, and sex. This study presents an innovative way to characterize on-screen violent content and demonstrates the extent to which risk behaviors co-occur within films. (Read the full article)

The widely disseminated National Institute on Alcohol Abuse and Alcoholism screening tool for adolescent alcohol use was developed based on epidemiologic data. It has not been validated in a clinical sample and does not screen for tobacco or drug use.

This study found that a measure that expanded the National Institute on Alcohol Abuse and Alcoholism adolescent alcohol use tool to include tobacco and drugs was sensitive and specific for identifying substance use disorders in a pediatric clinic patient population. (Read the full article)

Cotinine assays for dried blood spots have been developed but not deployed in a large sample of newborn specimens.

Cotinine levels consistent with active maternal smoking were detectable in 12% of newborn blood spots, although 41% of the mothers reportedly did not smoke. Data confirm that reported smoking during pregnancy is an imperfect measure of prenatal tobacco smoke exposure. (Read the full article)

Cigarette smoking during adolescence causes significant health problems. Health care providers play an important role in promoting tobacco use abstinence among adolescents, but recent data on the prevalence of provider screening and advice to adolescents are lacking.

This study uses nationally representative surveillance data to provide current estimates of self-reported receipt of health professional screening and advice about tobacco use among US adolescents. Cessation behaviors and correlates of past-year quit attempts among smokers were also explored. (Read the full article)

Parental smoking cessation helps eliminate children’s exposure to tobacco smoke. A child’s visit to the doctor provides a teachable moment for parental smoking cessation. Effective strategies to help parents quit smoking are available for implementation.

Evidence-based outpatient intervention for parents who smoke can be delivered successfully after the initial implementation. Maximizing parental quit rates in the pediatric context will require more complete and sustained systems-level integration. (Read the full article)

There is a debate about whether e-cigarettes will benefit public health. However, there is little knowledge about how e-cigarette users and dual users (those using both e-cigarettes and tobacco cigarettes) differ from other adolescents on a range of variables.

Teenagers who only used e-cigarettes were intermediate in levels of risk and protective factors between nonusers and those who used both cigarettes and e-cigarettes. This raises a question about whether e-cigarettes recruit low-risk youth to tobacco product use. (Read the full article)

Noncigarette tobacco products are increasingly popular among youth, especially youth who smoke cigarettes. Although youth use of conventional cigarettes is on the decline, use of other tobacco products is rising and multiple product use may be an escalating trend.

More than twice as many youth in the United States currently use 2 or more tobacco products than cigarettes alone. Youth multiple product use is associated with increased nicotine dependence, raising concerns about the additive harms of noncigarette tobacco products. (Read the full article)

Senate Bill 25 would raise the legal age to purchase tobacco products from 18 to 21 DOVER, Del. – Surrounded by members of the General Assembly, advocates, students, and health care professionals, Governor John Carney on Tuesday announced his support for Senate Bill 25 – legislation that would raise the legal age for sales of […]

Protecting the Health of our Young People, and our State’s Future, by Raising the Minimum Sales Age of Tobacco Products from 18 to 21 Op-ed by Karyl T. Rattay, MD, MS, Director, Division of Public Health, Delaware Department of Health and Social Services It’s a fact that most smokers start using tobacco as youth: Eighty-nine […]

Title: FDA to Regulate E-Cigarettes Just Like Tobacco
Category: Health News
Created: 4/28/2011 11:01:00 AM
Last Editorial Review: 4/28/2011 12:00:00 AM

Title: Tobacco Companies Must Put New Warnings on Packaging, Court Says
Category: Health News
Created: 5/1/2018 12:00:00 AM
Last Editorial Review: 5/2/2018 12:00:00 AM

Title: FDA OKs Restricted Sales of 'Heat-Not-Burn' Tobacco Devices
Category: Health News
Created: 4/30/2019 12:00:00 AM
Last Editorial Review: 5/1/2019 12:00:00 AM

We wish to thank J. Britton and co-workers for responding to our editorial and giving us an opportunity to clarify our position as well as correct a few misunderstandings. We definitely share the same goal, which is to relieve Europe and the rest of the world from the terrible results of the tobacco epidemic. We also do not "blankly oppose e-cigarettes"; however, we strongly advocate against a harm reduction strategy including e-cigarettes as well as heated tobacco products [1]. As clinicians we all see reluctant smokers where e-cigarettes can be tried as a last resort for getting off cigarette smoking, but that is of little relevance for a general harm reduction strategy. We also agree that the UK has achieved a lot in the area of smoking cessation but would argue that this has been achieved by impressive tobacco control, not by the use of e-cigarettes, and that a country such as Australia, which has banned nicotine-containing e-cigarettes, has achieved similar results.

The respiratory community is united in its desire to reduce and eliminate the harm caused by tobacco smoking, which is at present on course to kill one billion people in the 21st century. The stated policy of the European Respiratory Society is to strive "constantly to promote strong and evidence-based policies to reduce the burden of tobacco related diseases". In our view, the recent ERS Tobacco Control Committee statement on tobacco harm reduction [1], though well-intentioned, appears to be based on a number of false premises and draws its conclusions from a partial account of available data. It also presents a false dichotomy between the provision of "conventional" tobacco control and harm reduction approaches. We therefore respond, in turn, to the seven arguments presented against the adoption of harm reduction in the Committee's statement.

BACKGROUND AND OBJECTIVES:

A previous single-county study found that retail stores usually asked young-looking tobacco customers to show proof-of-age identification, but a large proportion of illegal tobacco sales to minors occurred after the customers had shown identification proving they were too young to purchase tobacco. We sought to investigate these findings on a larger scale.

Tobacco use is a persistent public health issue. It kills up to half its users and is the cause of nearly 90% of all lung cancers. The main psychoactive component of tobacco is nicotine, primarily responsible for its abuse-related effects. Accordingly, most pharmacotherapies for smoking cessation target nicotinic acetylcholine receptors (nAChRs), nicotine’s major site of action in the brain. The goal of the current review is twofold: first, to provide a brief overview of the most commonly used behavioral procedures for evaluating smoking cessation pharmacotherapies and an introduction to pharmacokinetic and pharmacodynamic properties of nicotine important for consideration in the development of new pharmacotherapies; and second, to discuss current and potential future pharmacological interventions aimed at decreasing tobacco use. Attention will focus on the potential for allosteric modulators of nAChRs to offer an improvement over currently approved pharmacotherapies. Additionally, given increasing public concern for the potential health consequences of using electronic nicotine delivery systems, which allow users to inhale aerosolized solutions as an alternative to smoking tobacco, an effort will be made throughout this review to address the implications of this relatively new form of nicotine delivery, specifically as it relates to smoking cessation.

Background:

Percent density (PD) is a strong risk factor for breast cancer that is potentially modifiable by lifestyle factors. PD is a composite of the dense (DA) and nondense (NDA) areas of a mammogram, representing predominantly fibroglandular or fatty tissues, respectively. Alcohol and tobacco use have been associated with increased breast cancer risk. However, their effects on mammographic density (MD) phenotypes are poorly understood.

Background:

Despite smoking being a well-established risk factor for pancreatic cancer, there is a need to further characterize pancreatic cancer risk according to lifespan smoking patterns and other smoking features, such as tobacco type. Our aim was to deeply investigate them within a large European case–control study.

Tobacco smoking is the primary risk factor for lung cancer, driven by the addictive nature of nicotine and the indisputable carcinogenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) as well as other compounds. The integration of lung cancer chemoprevention with smoking cessation is one potential approach to reduce this risk and mitigate lung cancer mortality. Experimental data from our group suggest that kava, commonly consumed in the South Pacific Islands as a beverage to promote relaxation, may reduce lung cancer risk by enhancing NNK detoxification and reducing NNK-derived DNA damage. Building upon these observations, we conducted a pilot clinical trial to evaluate the effects of a 7-day course of kava on NNK metabolism in active smokers. The primary objective was to compare urinary total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL plus its glucuronides, major metabolites of NNK) before and after kava administration as an indicator of NNK detoxification. Secondary objectives included determining kava's safety, its effects on DNA damage, tobacco use, and cortisol (a biomarker of stress). Kava increased urinary excretion of total NNAL and reduced urinary 3-methyladenine in participants, suggestive of its ability to reduce the carcinogenicity of NNK. Kava also reduced urinary total nicotine equivalents, indicative of its potential to facilitate tobacco cessation. Plasma cortisol and urinary total cortisol equivalents were reduced upon kava use, which may contribute to reductions in tobacco use. These results demonstrate the potential of kava intake to reduce lung cancer risk among smokers.

With the COVID-19 coronavirus causing a global pandemic, a look back at the scientists who figured out viruses and their relationship to disease

The country’s two biggest tobacco companies have agreed to improve public access to internal tobacco-industry documents and to pay $6.25 million into a court fund that will go to support the country’s largest online collection of tobacco documents.

Tobacco use remains the single largest preventable cause of death and disease in the United States, killing more than 480,000 Americans each year and incurring over $300 billion per year in costs for direct medical care and lost productivity. In addition, of all cigarettes sold in the U.S. in 2016, 35% were menthol cigarettes, which…

Tobacco use remains the single largest preventable cause of death and disease in the United States, killing more than 480,000 Americans each year and incurring over $300 billion per year in costs for direct medical care and lost productivity. In addition, of all cigarettes sold in the U.S. in 2016, 35% were menthol cigarettes, which…

Many clean tech wonks have never heard of them, but Alevo plans to be manufacturing grid-scale energy storage on a huge scale within the next few years.

The climate crisis and peak oil demand are making expensive projects like Alberta's Teck Frontier look like bad investments.

XVIII Habanos Festival: Once Again Havana Hosts the Major Annual Event of the World's Finest Tobacco, the Habano

CNBC's Jim Cramer said Friday that he's done with fossil fuel stocks because young investor's concerns about climate change are holding them down.

Eating too much salt can put you at a higher risk of a wide range of health problems, especially high blood pressure (hypertension). However, experts

Exports (Bop) - Food And Tobacco Intermediate Products in Canada increased to 534.20 CAD Million in March from 459 CAD Million in February of 2020. Exports (Bop) - Food And Tobacco Intermediate Prod in Canada averaged 249.03 CAD Million from 1988 until 2020, reaching an all time high of 617.40 CAD Million in February of 2016 and a record low of 37 CAD Million in December of 1989. This page includes a chart with historical data for Canada Exports of (bop) - Food And Tobacco Intermediate.

Exports (Bop) - Food, Beverage And Tobacco Products in Canada increased to 2685.50 CAD Million in March from 2594.50 CAD Million in February of 2020. Exports (Bop) - Food, Beverage And Tobacco Product in Canada averaged 1423.40 CAD Million from 1988 until 2020, reaching an all time high of 2808.70 CAD Million in December of 2016 and a record low of 425.60 CAD Million in March of 1989. This page includes a chart with historical data for Canada Exports of (bop) - Food, Beverage And Tobacco Pro.

Imports (Bop) - Food And Tobacco Intermediate Products in Canada increased to 307.40 CAD Million in March from 257 CAD Million in February of 2020. Imports (Bop) - Food And Tobacco Intermediate Prod in Canada averaged 177.85 CAD Million from 1988 until 2020, reaching an all time high of 329.30 CAD Million in April of 2014 and a record low of 55.10 CAD Million in September of 1988. This page includes a chart with historical data for Canada Imports of (bop) - Food And Tobacco Intermediate.

Imports of (bop) - Tobacco Products in Canada increased to 97 CAD Million in March from 84.30 CAD Million in February of 2020. Imports of (bop) - Tobacco Products in Canada averaged 53.60 CAD Million from 1988 until 2020, reaching an all time high of 227.80 CAD Million in September of 2019 and a record low of 2.40 CAD Million in July of 1988. This page includes a chart with historical data for Canada Imports of (bop) - Tobacco Products.

Exports of Prepared Foodstuffs Beverages & Tobacco in South Africa increased to 3490.92 ZAR Million in March from 2608.19 ZAR Million in February of 2020. Exports of Prepared Foodstuffs Beverages & Tobacco in South Africa averaged 2920.53 ZAR Million from 2014 until 2020, reaching an all time high of 4194.88 ZAR Million in October of 2018 and a record low of 1704.27 ZAR Million in January of 2015. This page includes a chart with historical data for South Africa Exports of Prepared Foodstuffs Beverages & Tobacco.

Imports of Prepared Foodstuffs Beverages & Tobacco in South Africa increased to 2612.43 ZAR Million in March from 2292.20 ZAR Million in February of 2020. Imports of Prepared Foodstuffs Beverages & Tobacco in South Africa averaged 2502.29 ZAR Million from 2014 until 2020, reaching an all time high of 3674.84 ZAR Million in October of 2019 and a record low of 1707.09 ZAR Million in June of 2014. This page includes a chart with historical data for South Africa Imports of Prepared Foodstuffs Beverages & Tobacco.

Exports (Fob): Primary Prds - Unmanufactured & Refuse Tobacco in Brazil increased to 3637.20 USD Million in April from 115.76 USD Million in March of 2020. Exports (Fob): Primary Prds - Unmanufactured & Ref in Brazil averaged 142.16 USD Million from 1989 until 2020, reaching an all time high of 3637.20 USD Million in April of 2020 and a record low of 3.97 USD Million in February of 1992. This page includes a chart with historical data for Brazil Exports of : Primary Prds - Unmanufactured &.

Imports Intra Eu - Tobacco & Manufactured Tobacco Substitutes in the United Kingdom decreased to 29.90 GBP Million in February from 43.46 GBP Million in January of 2020. Imports Intra Eu - Tobacco & Manufactured Tobacco in the United Kingdom averaged 29.27 GBP Million from 1996 until 2020, reaching an all time high of 168.67 GBP Million in June of 2010 and a record low of 7.42 GBP Million in April of 2001. This page includes a chart with historical data for the United Kingdom Imports of Intra EU - Tobacco & Manufactured Toba.

Imports - Tobacco & Manufactured Tobacco Substitutes in the United Kingdom decreased to 31.79 GBP Million in February from 44.09 GBP Million in January of 2020. Imports - Tobacco & Manufactured Tobacco Substitut in the United Kingdom averaged 40.91 GBP Million from 2000 until 2020, reaching an all time high of 189.40 GBP Million in March of 2012 and a record low of 12.14 GBP Million in November of 2019. This page includes a chart with historical data for the United Kingdom Imports Ofbacco & Manufactured Tobacco Substitutes.

Imports Tobacco & Tobacco Manufactures in Singapore decreased to 62.14 SGD Million in March from 76.15 SGD Million in February of 2020. Imports Tobacco & Tobacco Manufactures in Singapore averaged 99.50 SGD Million from 2014 until 2020, reaching an all time high of 150.29 SGD Million in December of 2018 and a record low of 62.14 SGD Million in March of 2020. This page includes a chart with historical data for Singapore Imports Ofbacco & Tobacco Manufactures.

Exports of Food Products, Beverage & Tobacco in Switzerland increased to 748.84 CHF Million in March from 690.61 CHF Million in February of 2020. Exports of Food Products, Beverage & Tobacco in Switzerland averaged 417.09 CHF Million from 1988 until 2020, reaching an all time high of 882.57 CHF Million in November of 2018 and a record low of 132.60 CHF Million in January of 1988. This page includes a chart with historical data for Switzerland Exports of Food Products, Beverage & Tobacco.

Imports of Beverages & Tobacco in Japan increased to 76597.82 JPY Million in March from 59348.14 JPY Million in February of 2020. Imports of Beverages & Tobacco in Japan averaged 46130.71 JPY Million from 1983 until 2020, reaching an all time high of 100314.43 JPY Million in October of 2017 and a record low of 7661.39 JPY Million in July of 1986. This page includes a chart with historical data for Japan Imports of Beverages & Tobacco.

Imports Tobacco & Tobacco Manufactures in Japan increased to 52874.62 JPY Million in March from 36315.01 JPY Million in February of 2020. Imports Tobacco & Tobacco Manufactures in Japan averaged 29208.68 JPY Million from 1988 until 2020, reaching an all time high of 71210.89 JPY Million in October of 2017 and a record low of 8285.55 JPY Million in August of 1988. This page includes a chart with historical data for Japan Imports Ofbacco & Tobacco Manufactures.

Imports of Beverages & Tobacco in Australia increased to 262 AUD Million in March from 220 AUD Million in February of 2020. Imports of Beverages & Tobacco in Australia averaged 118.89 AUD Million from 1988 until 2020, reaching an all time high of 410 AUD Million in October of 2019 and a record low of 19 AUD Million in April of 1988. This page includes a chart with historical data for Australia Imports of Beverages & Tobacco.